IBB Stock UPDATES Nasdaq Biotechnology Ishares (IBB) 273.35 09/11/2014

New Post Public Reply Private Reply Replies (0) Message Board
Stock_Tracker
Nasdaq Biotechnology Ishares (IBB) 273.35 $IBB

After Yesterday's Rally of 1.85% Shares Could Potentially Pullback
Comtex SmarTrend(R) - Wed Sep 10, 4:08PM CDT
iShares Nasdaq Biotechnology Index (AMEX:IBB) traded in a range yesterday that spanned from a low of $269.51 to a high of $274.64. Yesterday, the shares gained 1.9%, which took the trading range above the 3-day high of $273.23 on volume of 750,000 shares. Often times after large one-day gains, short term traders will seek to take profits and, as such, investors should be cautious.

iShares Nasdaq Biotechnology Index Set to Possibly Pullback After Yesterday's Rally of 1.85%
Comtex SmarTrend(R) - Wed Sep 10, 4:07PM CDT
iShares Nasdaq Biotechnology Index (AMEX:IBB) traded in a range yesterday that spanned from a low of $269.51 to a high of $274.64. Yesterday, the shares gained 1.9%, which took the trading range above the 3-day high of $273.23 on volume of 750,000 shares. Often times after large one-day gains, short term traders will seek to take profits and, as such, investors should be cautious.

Biotech ETFs Slip on Gilead Weakness; Buying Opportunity Now? - ETF News And Commentary
Zacks Equity Research - ZACKS - Wed Sep 10, 11:00AM CDT
A look at biotech ETFs following some weakness in one of the key companies in the space, Gilead (GILD).

Watch for iShares Nasdaq Biotechnology Index to Potentially Rebound After Falling 1.65% Yesterday
Comtex SmarTrend(R) - Thu Sep 04, 3:50PM CDT
iShares Nasdaq Biotechnology Index (AMEX:IBB) traded in a range yesterday that spanned from a low of $270.23 to a high of $276.22. Yesterday, the shares fell 1.6%, which took the trading range below the 3-day low of $273.85 on volume of 1.2 million shares. Often times after large one-day declines, short-term traders may play for some degree of mean reversion.

iShares Nasdaq Biotechnology Index Set to Possibly Rebound After Yesterday's Selloff of 1.65%
Comtex SmarTrend(R) - Thu Sep 04, 3:50PM CDT
iShares Nasdaq Biotechnology Index (AMEX:IBB) traded in a range yesterday that spanned from a low of $270.23 to a high of $276.22. Yesterday, the shares fell 1.6%, which took the trading range below the 3-day low of $273.85 on volume of 1.2 million shares. Often times after large one-day declines, short-term traders may play for some degree of mean reversion.

Are Biotech ETFs Back on Track? - ETF News And Commentary
Zacks Equity Research - ZACKS - Wed Aug 27, 7:00AM CDT
Recent trends have been very favorable for the biotech sector, but can this run continue?

After Recent Surge, Are Biotech ETFs Back on Track? - ETF News And Commentary
Zacks Equity Research - Zacks Investment Research - Wed Aug 27, 7:00AM CDT
Recent trends have been very favorable for the biotech sector, but can this run continue?

Biotech Stock Boom Times Are Back
at The Street - Tue Aug 26, 6:00AM CDT
The iShares Nasdaq Biotechnology ETF closed at 272.63 Monday, less than one point below the year (and all-time) closing high reached on Feb. 25.

'Fast Money' Recap: Next Stop, S&P 2,100?
at The Street - Tue Aug 26, 4:00AM CDT
The trading panel looked at banks and the top buy and sell candidates for right now.

Look for Shares of iShares Nasdaq Biotechnology Index to Potentially Pullback after Yesterday's 2.33% Rise
Comtex SmarTrend(R) - Mon Aug 25, 4:07PM CDT
iShares Nasdaq Biotechnology Index (AMEX:IBB) traded in a range yesterday that spanned from a low of $268.75 to a high of $272.88. Yesterday, the shares gained 2.3%, which took the trading range above the 3-day high of $268.60 on volume of 1.1 million shares. Often times after large one-day gains, short term traders will seek to take profits and, as such, investors should be cautious.

After Yesterday's Rally of 2.33% Shares Could Potentially Pullback
Comtex SmarTrend(R) - Mon Aug 25, 4:06PM CDT
iShares Nasdaq Biotechnology Index (AMEX:IBB) traded in a range yesterday that spanned from a low of $268.75 to a high of $272.88. Yesterday, the shares gained 2.3%, which took the trading range above the 3-day high of $268.60 on volume of 1.1 million shares. Often times after large one-day gains, short term traders will seek to take profits and, as such, investors should be cautious.

Economic Recovery Doesn't Satisfy Fed as Stocks Soar Higher
at The Street - Thu Aug 21, 10:14AM CDT
Low inflation and slack in the labor market has kept policymakers dovish, leading to strength in U.S. equities and in high-beta sectors.

Nasdaq Composite: What Are You Buying That's Driving New Highs? - Real Time Insight
Zacks Equity Research - ZACKS - Mon Aug 18, 1:04PM CDT
It's not just the big caps attracting all the money

Eased Geopolitical Tensions Have Little Effect on Interest Rates
at The Street - Fri Aug 15, 11:16AM CDT
It seems that no matter what, investors just want a reason to continue buying bonds and pressuring rates lower.

SmarTrend Watching for Potential Pullback in Shares of iShares Nasdaq Biotechnology Index After 2.17% Gain
Comtex SmarTrend(R) - Wed Aug 13, 3:58PM CDT
iShares Nasdaq Biotechnology Index (AMEX:IBB) traded in a range yesterday that spanned from a low of $252.61 to a high of $257.59. Yesterday, the shares gained 2.2%, which took the trading range above the 3-day high of $254.75 on volume of 1.1 million shares. Often times after large one-day gains, short term traders will seek to take profits and, as such, investors should be cautious.

iShares Nasdaq Biotechnology Index Rises 2.17% on Heavy Volume: Watch For Potential Pullback
Comtex SmarTrend(R) - Wed Aug 13, 3:58PM CDT
iShares Nasdaq Biotechnology Index (AMEX:IBB) traded in a range yesterday that spanned from a low of $252.61 to a high of $257.59. Yesterday, the shares gained 2.2%, which took the trading range above the 3-day high of $254.75 on volume of 1.1 million shares. Often times after large one-day gains, short term traders will seek to take profits and, as such, investors should be cautious.

'Fast Money' Recap: Can You Trust This Rally?
at The Street - Tue Aug 12, 4:00AM CDT
The trading panel discussed whether the Federal Reserve is having more of an effect on the markets than geopolitical events.




Scroll down for more posts ▼

Top 10 Most Recent News Articles

DriveNets' Big Role at FYUZ 26: AI Fabrics Spotlighted

Updated Category News Views 78

Networking Titans Gather at FYUZ 26 Alright, folks, mark the first week of November as a field day for telecom and AI networking enthusiasts. DriveNets, a seasoned player in large-scale networking, is joining forces with some of the industry's giants—AT&T, KDDI, and Broadcom—at the Telecom Infra Project's flagship event, FYUZ 26, unfolding at The Westin Seattle. From...

Continue Reading
Nexus Capital Buys Coldwater Creek, Eyes Growth Surge

Updated Category News Views 87

A New Chapter in Apparel Investment You know when you're flipping through those catalog pages or hitting up e-commerce sites, just to find that perfect piece of clothing for a special someone—and you stick with a brand not just outta habit, but 'cause they've got a piece of your history? That's Coldwater Creek and Soft Surroundings, two brands that's been keepin' their...

Continue Reading
New Leadership at Carnegie Mellon's SEI Under Jason Brown

Updated Category News Views 0

Pivotal Leadership Change at Carnegie Mellon's SEI Big moves are coming out of Pittsburgh, folks. Carnegie Mellon University just shook things up by naming Jason M. Brown as the next director and CEO of their Software Engineering Institute (SEI). This signal-fire moment catches my eye as the SEI stands at the cutting edge of software, artificial intelligence, and...

Continue Reading
Harel Insurance Preps Q3 2026 Earnings Report

Updated Category News Views 96

Harel's Financial Spotlight: Next Moves on November 23, 2026 Harel Insurance Investments, a bigwig in the Israeli insurance landscape, is about to pull back the curtain on its third quarter 2026 financial report. Come November 23, the numbers will hit the streets, and every investor's gotta be asking: what's the latest play from Harel? Exploring Harel's Strategic...

Continue Reading
Leadership Shifts in AAOMS: Dr. Crago at Helm

Updated Category News Views 27

New Guard at AAOMS: Dr. Crago Takes Charge With a blend of experience and a fresh theme, Dr. Charles A. Crago steps into the presidential shoes of the American Association of Oral and Maxillofacial Surgeons (AAOMS) for the 2026-27 term. Frankly, navigating leadership isn't new to Crago. I mean, after serving a lifetime in varied roles—President-Elect, Vice President,...

Continue Reading
Milwaukee Cylinder Unveils Tech for Longevity in Tough Conditions

Updated Category News Views 115

Innovation Meets Contamination: ABC™ Technology Unleashed In the gritty halls of industrial manufacturing, equipment uptime can be the thin red line between profit and chaos. Milwaukee Cylinder just kicked it up a notch with their latest concoction: Active Barrier Chamber (ABC™) technology. This gizmo isn't just another shiny trinket; it's a genuine attempt to wrestle...

Continue Reading
Global Mayors Dialogue 2026: Ningbo Leads in Urban Ideas

Updated Category News Views 134

New Waves in City Collaboration Get this: from November 2 to 5, Ningbo, a key city nestled in east China's Zhejiang Province, is rolling out the red carpet for the 2026 Global Mayors Dialogue. Nearly 200 influential figures zooming into this seaside city isn't just for some aimless chit-chat. At the core, the theme is "Openness and Connectivity for Shared Opportunities."...

Continue Reading
Multi-mind Mayhem: Anime Debut Shakes Things Up

Updated Category News Views 43

Anime on the Horizon: What's the Buzz? Ever thought about living in a world where one body can carry three entirely different minds? Well, that's precisely what the TV anime Multi-mind Mayhem is all set to bring to the table. Announced by YTE LTD., this intriguing series will hit the screens in January 2027. Fans have been given a sneak peek with the first key visual and...

Continue Reading
Monetary Metals' Bold $38M Gold Bond: A Strategic Leap

Updated Category News Views 107

A Golden Opportunity in Uncertain Times Monetary Metals just pulled a rabbit outta the hat with this $38 million gold bond. That’s tripling the size from their 2024 offering. Normally, I'm skeptical about flashy bond numbers, but there's a glint of genius here. In a world teetering on the brink of financial chaos, investors are itching for something solid. And gold?...

Continue Reading
Sirolimus-Coated Balloon Shows Promise in TRANSFORM II

Updated Category News Views 96

Breaking Down the TRANSFORM II Trial Innovation never rests, folks, especially when it comes to treating coronary artery disease. Right on cue, the TRANSFORM II trial's results have hit the airwaves, marking a significant milestone with its implant-free MagicTouch Sirolimus-Coated Balloon (SCB) strategy. Getting the Lay of the Land This wasn't just some backyard...

Continue Reading

Top 5 Most Recently Viewed Articles

Investors Urged to Participate in Telix Pharmaceuticals Class Action

Updated Category News Views 116

Investors Encouraged to Engage in Telix Pharmaceuticals Case Telix Pharmaceuticals Ltd. (NASDAQ: TLX) has recently been in the spotlight due to significant allegations of securities fraud. Investors who purchased securities between certain dates in 2025 are being invited to participate in a class-action lawsuit that aims to hold the company accountable for misleading...

Continue Reading
Kellen Booher Appointed President and COO of CopperPoint

Updated Category News Views 334

Kellen Booher Joins CopperPoint as President & Chief Operating Officer Momentum continues to build for CopperPoint with the announcement of Kellen Booher joining the company’s executive team as President and Chief Operating Officer. With profound experience in the insurance sector, Booher’s arrival signifies a vital shift in leadership that aims to further enhance...

Continue Reading
Creatd, Inc. Completes Flewber Acquisition to Revolutionize Air Travel

Updated Category News Views 109

Transforming Air Travel Through Innovative Acquisitions Creatd, Inc. has made a significant move in the private aviation sector by finalizing its acquisition of Flewber Global, Inc. for a total of $8.3 million. This strategic acquisition sets the stage for the rebranding of Flewber into Flyte, Inc., a next-generation platform focused on regional air mobility. With this...

Continue Reading
Tesla's Q4 Earnings Insights: What Analysts Are Saying

Updated Category News Views 264

Tesla's Upcoming Financial Report: A Look Ahead Tesla (NASDAQ: TSLA) is expected to unveil its fourth-quarter 2024 financial results soon, and many are eager to learn what the numbers will reveal. Analysts from Morgan Stanley have shared their expectations and insights ahead of this important announcement, which is set to occur after markets close on an agreed date....

Continue Reading
Navigating Nuclear Energy for Tech's AI Needs: A Complex Journey

Updated Category News Views 97

Overcoming the Hurdles of Nuclear Energy for AI Development The swift growth of artificial intelligence (AI) technologies has led to a big increase in energy demand. To address this, Constellation Energy and Microsoft (NASDAQ: MSFT) are turning to the Three Mile Island nuclear plant as a potential provider of environmentally friendly energy to power the data centers...

Continue Reading